ストックスクリーナーアプリを入手
38.01
4.45%
1.62
プレマーケット:
40.01
2.00
+5.26%
前日終値:
$36.39
開ける：
$36.53
24時間の取引高:
2.52M
Relative Volume:
1.17
時価総額：
$5.79B
収益：
$3.44B
当期純損益:
$-8.30M
株価収益率:
-255.62
EPS:
-0.1487
ネットキャッシュフロー:
$43.30M
1週間 パフォーマンス:
+4.83%
1か月 パフォーマンス:
+3.40%
6か月 パフォーマンス:
-5.45%
1年 パフォーマンス:
-6.68%
1日の値動き範囲:
$36.53
$38.53
1週間の範囲:
$33.80
$38.53
52週間の値動き範囲:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
38.01 | 5.79B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 開始されました | Goldman | Sell |
| 2025-11-20 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Bruker shares rise 4% on first quarter earnings beat By Investing.com - Investing.com Canada
Bruker: Q1 Earnings Snapshot - KVUE
Bruker (NASDAQ: BRKR) Q1 2026 revenue rises 2.7% as FY26 outlook held - Stock Titan
Bruker sales rose, but earnings fell as it kept 2026 forecast - Stock Titan
MSN Money - MSN
Bruker earnings on deck as first quarter results loom Wednesday By Investing.com - Investing.com Canada
Bruker earnings on deck as first quarter results loom Wednesday - Investing.com
Related_a1otxm - MSN
Earnings Preview: Bruker Corp to Report Financial Results Pre-market on May 06 - Moomoo
Bruker Launches High-Throughput Molecular Diagnostic System for Infectious Diseases in Europe - Clinical Lab Products
Bruker Corp (BRKR) Shares Fall 5.4% -- What GF Score of 81 Tells Investors - GuruFocus
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Bruker (BRKR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker enhances MALDI and IR Biotyper for infection control - SelectScience
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp | 8-K: Current report - Moomoo
Bruker (NASDAQ: BRKR) sets $3.9844 dividend on 6.375% preferred - Stock Titan
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 135,470 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Hits Day Low at $34.88 Amid Price Pressure - Markets Mojo
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Bruker acquires Austria based biocrates - MSN
Peregrine Capital Management LLC Raises Holdings in Bruker Corporation $BRKR - MarketBeat
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Bruker Corp (BRKR) Stock Down 8.7% -- Now Undervalued? GF Score: 81/100 - GuruFocus
Bruker (NASDAQ:BRKR) Stock Price Down 8.7%Time to Sell? - MarketBeat
Trending Industry Today: Bruker Corp Leads Losses In Room-Temp Superconductors Stocks - Moomoo
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Is Bruker (BRKR) Fairly Priced After Recent Short Term Share Price Rebound? - Yahoo Finance
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - 富途牛牛
Bruker Corp stock (US1167941087): Is its scientific instruments edge strong enough for steady growth - AD HOC NEWS
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer M - GuruFocus
Bruker (BRKR) Unveils Innovations for Cancer Research at Upcomin - GuruFocus
A Look at Bruker Corp (BRKR) After 4.5% Gain -- GF Value $71.47 vs Price $40.70 - GuruFocus
Bruker unveils spatial biology workflows, opens PaintScape pre-orders By Investing.com - Investing.com Canada
Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker expands microbiology portfolio with new testing tools By Investing.com - Investing.com South Africa
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.93%
大文字化:
|
ボリューム (24 時間):